Target Price | $172.68 |
Price | $121.41 |
Potential | 42.23% |
Number of Estimates | 53 |
53 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $172.68. This is 42.23% higher than the current stock price. The highest price target is $235.92 94.32% , the lowest is $120.00 1.16% . | |
A rating was issued by 67 analysts: 62 Analysts recommend NVIDIA to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 42.23% . Most analysts recommend the NVIDIA stock at Purchase. |
56 Analysts have issued a sales forecast NVIDIA 2026 . The average NVIDIA sales estimate is $205b . This is 57.18% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $246b 88.15% , the lowest is $177b 35.56% .
This results in the following potential growth metrics:
2025 | $130b | 114.20% |
---|---|---|
2026 | $205b | 57.18% |
2027 | $253b | 23.29% |
2028 | $295b | 16.56% |
2029 | $306b | 3.78% |
2030 | $309b | 1.13% |
20 Analysts have issued an NVIDIA EBITDA forecast 2026. The average NVIDIA EBITDA estimate is $132b . This is 58.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $156b 87.51% , the lowest is $122b 46.70% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $83.3b | 141.64% |
---|---|---|
2026 | $132b | 58.52% |
2027 | $167b | 26.25% |
2028 | $191b | 14.29% |
2029 | $228b | 19.65% |
2025 | 63.85% | 12.81% |
---|---|---|
2026 | 64.39% | 0.85% |
2027 | 65.94% | 2.41% |
2028 | 64.65% | 1.96% |
2029 | 74.54% | 15.30% |
32 NVIDIA Analysts have issued a net profit forecast 2026. The average NVIDIA net profit estimate is $108b . This is 49.48% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $130b 81.29% , the lowest is $95.5b 32.65% .
This results in the following potential growth metrics and future Net Margins:
2025 | $72.0b | 147.06% |
---|---|---|
2026 | $108b | 49.48% |
2027 | $138b | 28.35% |
2028 | $164b | 18.59% |
2025 | 55.14% | 15.34% |
---|---|---|
2026 | 52.45% | 4.89% |
2027 | 54.60% | 4.10% |
2028 | 55.54% | 1.72% |
32 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA EPS is $4.39 . This is 49.32% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.33 81.29% , the lowest is $3.90 32.65% .
This results in the following potential growth metrics and future valuations:
2025 | $2.94 | 147.06% |
---|---|---|
2026 | $4.39 | 49.32% |
2027 | $5.64 | 28.47% |
2028 | $6.69 | 18.62% |
Current | 41.30 | 47.72% |
---|---|---|
2026 | 27.63 | 33.10% |
2027 | 21.52 | 22.11% |
2028 | 18.15 | 15.66% |
Based on analysts' sales estimates for 2026, the NVIDIA stock is valued at an EV/Sales of 14.28 and an P/S ratio of 14.44 .
This results in the following potential growth metrics and future valuations:
Current | 22.45 | 40.75% |
---|---|---|
2026 | 14.28 | 36.38% |
2027 | 11.58 | 18.89% |
2028 | 9.94 | 14.21% |
2029 | 9.58 | 3.64% |
2030 | 9.47 | 1.12% |
Current | 22.70 | 40.47% |
---|---|---|
2026 | 14.44 | 36.38% |
2027 | 11.71 | 18.89% |
2028 | 10.05 | 14.21% |
2029 | 9.68 | 3.64% |
2030 | 9.58 | 1.12% |
Analyst | Rating | Action | Date |
---|---|---|---|
DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Mar 20 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Mar 20 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
Keybanc |
Overweight
➜
Overweight
|
Unchanged | Mar 19 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Mar 19 2025 |
Analyst Rating | Date |
---|---|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Mar 20 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Mar 20 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Mar 19 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Mar 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.